Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Michael Voiles

Physician Assistant Grandville, MI Physician Assistant

NPI 1881000107 CMS profile 10713276

6105 Wilson Ave Sw Ste 202, Grandville, MI 49418

Open in the dashboard

General payments

$7,459

351 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Voiles of Grandville, MI is reported in the CMS Open Payments database as having received $7,459 across 351 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,965 81
2024 General $2,054 95
2023 General $1,621 81
2022 General $1,577 80
2021 General $242 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Voiles
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Michael Voiles were reported at $1,965. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Michael Voiles Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $242 $132 $37–$438 $132
2022 $1,577 $155 $48–$522 $149
2023 $1,621 $167 $52–$557 $160
2024 $2,054 $178 $55–$600 $164
2025 $1,965 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Novo Nordisk Inc $938 52 payments
  2. AstraZeneca Pharmaceuticals LP $773 34 payments
  3. ITI, Inc. $738 35 payments
  4. Pfizer Inc. $556 29 payments
  5. AbbVie, Inc. $477 20 payments
  6. Teva Pharmaceuticals USA, Inc. $381 21 payments
  7. Lundbeck LLC $373 17 payments
  8. Biohaven Pharmaceutical Holding Company Ltd. $366 19 payments
  9. Astellas Pharma US Inc $323 12 payments
  10. Neurocrine Biosciences, Inc. $306 13 payments
  11. Other $2,227 99 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $7,333 348 payments
  2. Debt forgiveness $79 2 payments
  3. Education $47 1 payment
Products named General payments · program years 2021–2025
  1. Ozempic $737 40 payments
  2. RYBELSUS $669 37 payments
  3. CAPLYTA $669 32 payments
  4. NURTEC ODT Pain $556 29 payments
  5. FARXIGA $476 21 payments
  6. ZAVZPRET $397 22 payments
  7. NURTEC ODT Primary Care $366 19 payments
  8. INGREZZA $306 13 payments
  9. Veozah $297 11 payments
  10. QULIPTA $262 14 payments
  11. Other $4,578 216 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

351 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record